| Pharmaceutical active ingredients: |
| NystatinTriamcinolone Acetonide |
| Available forms, composition and doses of Mytrex F: |
| Cream; Topical; Nystatin 100,000 units; Triamcinolone Acetonide 0.1%Ointment; Topical; Nystatin 100,000 units; Triamcinolone Acetonide 0.1% |
| Mytrex F medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AA01 - NystatinD07CB01 - Triamcinolone and antibiotics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Savage Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mytozytrex | Mitomycin | SuperGen |
| My-Trans | Meprobamate | Unidentified Pharmaceutical Company |
| Mytrate | Epinephrine | Unidentified Pharmaceutical Company |
| Mytrex | Nystatin; Triamcinolone Acetonide | Altana Pharma |
| Mytrex A | Neomycin Sulfate; Triamcinolone Acetonide | Savage Laboratories |
| Mytrocin | Nitrofurazone | Greater Pharma |
| Mytusan DM | Dextromethorphan Hydrobromide | Am-Europharma |
| Mytussin | Guaifenesin | Morton Grove Pharmaceuticals |
| Mytussin AC | Codeine Phosphate; Guaifenesin | Morton Grove Pharmaceuticals |
| Mytussin CF | Dextromethorphan Hydrobromide; Guaifenesin; Phenylpropanolamine Hydrochloride | Morton Grove Pharmaceuticals |